Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

15.0K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.0K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

573
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
573
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

175
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
175

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GATSBI: improving context-aware protein embeddings through biologically motivated data splits.

Bioinformatics (Oxford, England)·2026
Same author

Global population frequencies of <i>NAT2</i> star alleles observed in three large biobanks.

medRxiv : the preprint server for health sciences·2026
Same author

Severe Thiopurine-Induced Myelosuppression in a Pediatric Acute Lymphoblastic Leukemia Patient With the NUDT15 *1/*6 Genotype: A Brief Report.

Clinical and translational science·2026
Same author

Exome-wide association study of blood lipids in 1,158,017 individuals from diverse populations.

Nature genetics·2026
Same author

PharmVar GeneFocus: CYP1A2-Clinical Impact, Genetic Variation, and Updated Nomenclature.

Clinical pharmacology and therapeutics·2026
Same author

Genomic Insights Into Risperidone Treatment Outcomes in Children and Adolescents: Experience From a Psychiatric Hospital Serving Rural Youth.

Clinical pharmacology and therapeutics·2026

Related Experiment Video

Updated: Dec 2, 2025

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
07:00

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

Published on: April 1, 2019

10.3K

Transfer learning enables prediction of CYP2D6 haplotype function.

Gregory McInnes1, Rachel Dalton2,3, Katrin Sangkuhl4

  • 1Biomedical Informatics Training Program, Stanford University, Stanford, California, United States of America.

Plos Computational Biology
|November 2, 2020
PubMed
Summary

A new AI tool, Hubble.2D6, accurately predicts the function of Cytochrome P450 2D6 (CYP2D6) gene variations. This advances personalized medicine by identifying individuals at risk for adverse drug reactions due to poor drug metabolism.

More Related Videos

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

894
The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

19.7K

Related Experiment Videos

Last Updated: Dec 2, 2025

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
07:00

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

Published on: April 1, 2019

10.3K
Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

894
The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

19.7K

Area of Science:

  • Pharmacogenomics
  • Computational Biology
  • Genetics

Background:

  • Cytochrome P450 2D6 (CYP2D6) is a key pharmacogene influencing drug metabolism and response.
  • Genetic variations in CYP2D6 cause significant inter-individual differences in drug efficacy and toxicity.
  • Current methods for assigning CYP2D6 haplotype function rely on manual literature curation, which is challenging to maintain with new discoveries.

Purpose of the Study:

  • To develop an automated method for predicting the functional status of CYP2D6 haplotypes using sequence data.
  • To address the challenge of maintaining accurate functional assignments for an increasing number of discovered CYP2D6 haplotypes.

Main Methods:

  • A convolutional neural network, named Hubble.2D6, was trained to predict CYP2D6 haplotype function.
  • The model utilized two pre-training steps with both real and simulated genetic data.
  • Model performance was evaluated on a held-out test set and compared against in vitro functional data.

Main Results:

  • Hubble.2D6 achieved 88% accuracy in predicting CYP2D6 haplotype functional status on an independent test set.
  • The model explained 47.5% of the variance in in vitro functional data for CYP2D6 star alleles with previously unknown function.
  • Hubble.2D6 demonstrates strong predictive power for uncharacterized CYP2D6 haplotypes.

Conclusions:

  • Hubble.2D6 is a promising computational tool for assigning function to novel CYP2D6 haplotypes.
  • This AI-driven approach can aid in identifying individuals at risk of being poor metabolizers, thereby improving drug safety.
  • The tool facilitates more efficient and accurate pharmacogenetic assessments for personalized medicine.